ARTICLE | Clinical News
Oral omecamtiv mecarbil: Phase II data
November 2, 2015 8:00 AM UTC
Top-line data from the dose-expansion portion of the double-blind, international Phase II COSMIC-HF trial in 448 patients with chronic heart failure (CHF) and left ventricular systolic dysfunction sho...